Header Logo

Connection

Laurel Habel to Hypoglycemic Agents

Back to Details
This is a "connection" page, showing publications Laurel Habel has written about Hypoglycemic Agents.
Laurel Habel
Connection Strength
1.987
Hypoglycemic Agents
  1. Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9.
    View in: PubMed
    Score: 0.431
  2. Metformin use and lung cancer risk in patients with diabetes. Cancer Prev Res (Phila). 2015 Feb; 8(2):174-9.
    View in: PubMed
    Score: 0.406
  3. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.311
  4. Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus. Gastroenterology. 2008 Dec; 135(6):1914-23, 1923.e1.
    View in: PubMed
    Score: 0.261
  5. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.246
  6. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
    View in: PubMed
    Score: 0.105
  7. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
    View in: PubMed
    Score: 0.096
  8. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.093
  9. Diabetes and cancer: a consensus report. Diabetes Care. 2010 Jul; 33(7):1674-85.
    View in: PubMed
    Score: 0.018
  10. Diabetes and cancer: a consensus report. CA Cancer J Clin. 2010 Jul-Aug; 60(4):207-21.
    View in: PubMed
    Score: 0.018

© 2024 Kaiser Permanente